GlassScriptPhysician profile
Edward Czinn
NPI 1194787812
$3,672.03
in general payments reported to CMS, 2019-2025
31 companies · $632 in 2025
The $632 reported for 2025 was more than what 92% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $414 · 2020: $284 · 2021: $201 · 2022: $710 · 2023: $505 · 2024: $927 · 2025: $632.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,062.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $500.34 | 2019-2025 | Bridion |
| Pacira Pharmaceuticals Incorporated | $412.23 | 2020-2023 | Iovera |
| Heron Therapeutics, INC. | $188.72 | 2022-2024 | Aponvie |
| Innovation Technologies INC | $163.80 | 2025 | Irrisept |
| Atricure, INC. | $161.74 | 2024 | |
| Medtronic, INC. | $155.36 | 2021-2025 | Becker, Shiley, Azure Xt Dr Mri Surescan |
| Solventum Corporation | $153.29 | 2025 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Medical Device Business Services, INC. | $146.05 | 2024 | |
| Eagle Pharmaceuticals, INC. | $142.04 | 2023-2024 | |
| Cumberland Pharmaceuticals, INC. | $139.40 | 2020-2025 | Caldolor |
| Aroa Biosurgery Incorporated | $137.99 | 2023 | |
| Abiomed | $133.35 | 2024 | Impella |
| Acell, INC. | $125.00 | 2019 | |
| Ethicon US, LLC | $125.00 | 2025 | Vistaseal |
| Astrazeneca Pharmaceuticals LP | $125.00 | 2022 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $108.14 | 2019-2025 | General - Metal Stents - G.I. |
| W. L. Gore & Associates, INC. | $100.72 | 2024 | Gore Enform Preperitoneal Biomaterial |
| Abbott Laboratories | $98.68 | 2020 | |
| Mindray Ds USA, INC. | $90.54 | 2022-2025 | Te X, Te7 Max |
| Edwards Lifesciences Corporation | $88.84 | 2024 | Hemosphere |
| Masimo Corporation | $55.07 | 2021-2023 | Sedline |
| Mallinckrodt Enterprises LLC | $52.78 | 2019 | |
| Csl Behring | $46.51 | 2019-2021 | |
| Karl Storz Endoscopy-America | $44.26 | 2022 | |
| Vyaire Medical, INC. | $38.49 | 2022 | |
| Medtronic Vascular, INC. | $38.39 | 2020 | |
| Paratek Pharmaceuticals, INC. | $30.95 | 2021 | |
| Mercury Enterprises, INC. | $22.63 | 2022 | |
| Medtronic USA, INC. | $17.83 | 2019 | |
| Ambu INC. | $15.49 | 2021 | |
| Fujifilm Sonosite, INC. | $13.40 | 2023 | Sonosite Lx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Czinn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.